Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice-Reference-Cited by-同舟云学术

Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice

Published:2023-10-19 Issue:1 Volume:37 Page:
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Manova Manoela¹²,Arabadjiev Jeliazko³,Mangaldzhiev Radoslav⁴,Dudov Assen⁵,Penchev Daniel⁶,Hemetsberger Margit⁷,Sharkov Arkadi⁸,Zidarova Boryana²,Apostolova Dimitrina²,Vasileva Maria²,Terezova Silvia²,Vlaskovska Mila²,Savova Alexandra¹²

Affiliation:

1. Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria

2. National Council on Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria

3. Medical oncology, University Hospital Acibadem City Clinic Tokuda, Sofia, Bulgaria

4. Specialized Hospital for Active Treatment of Oncological Diseases Ltd, Sofia, Bulgaria

5. Acibadem City Clinic Mladost Hospital, Sofia, Bulgaria

6. Sqilline, Sofia, Bulgaria

7. Hemetsberger Medical Services, Vienna, Austria

8. Department of Communication, Faculty of Journalism, Sofia University ‘St. Kliment Ohridski’, Sofia, Bulgaria

Funder

National Recovery and Resilience Plan of the Republic of Bulgaria

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2023.2268753

Reference30 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

2. Surveillance E and End Results Program. Cancer stat facts: breast. 2023. Available from: https://seer.cancer.gov/statfacts/html/breast.html

3. European Commission. Breast cancer burden in EU-27. 2020. Available from: https://ecis.jrc.ec.europa.eu/pdf/Breast_cancer_factsheet-Oct_2020.pdf

4. The Global Cancer Observatory. GLOBOCAN - cancer fact sheet: Bulgaria. 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/100-bulgaria-fact-sheets.pdf

5. Expression and significance of Wnt signaling components and their target genes in breast carcinoma